Skip to main content
. 2022 Oct 15;4(4):100251. doi: 10.1016/j.infpip.2022.100251

Table V.

Multivariate analysis of factors associated with reporting of side-effects following booster dose of Pfizer-BioNTech (BNT162b2) vaccine among the participants (n = 370)

Variable aOR 95% CI P-value
Gender (female) 2.286 0.803, 6.508 0.121
History of comorbidities 3.434 1.116, 10.569 0.031∗
History of COVID-19 infection 1.860 0.642, 5.384 0.253